| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,520,762 | 1,474,075 | 1,185,397 | 385,308 | | Cost of Revenue | 1,263,293 | 1,220,059 | 967,155 | 298,974 | | | Gross Profit | 257,469 | 254,016 | 218,242 | 86,334 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 203,695 | 203,604 | 181,535 | 65,432 | | Non Recurring | 339 | 3,793 | 32 | 811,784 | | Others | 8,079 | 8,656 | 7,788 | 6,024 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 45,356 | 37,963 | 28,887 | (796,906) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,997 | 22 | 41 | 639 | | Earnings Before Interest And Taxes | 49,353 | 37,985 | 28,928 | (796,267) | | Interest Expense | 17,367 | 32,818 | 21,679 | 14,787 | | Income Before Tax | 31,986 | 5,167 | 7,249 | (811,054) | | Income Tax Expense | 13,506 | 2,325 | 3,262 | (150,104) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,480 | 2,842 | 3,987 | (660,950) | | | Non-recurring Events | | Discontinued Operations | (2,886) | (2,816) | (2,309) | (24,647) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,594 | 26 | 1,678 | (685,597) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,594 | $26 | $1,678 | ($685,597) |
|
0.26% Nasdaq 
0.02 (0.18%) 
Income Statement
